Universal Facemask Adapter (UFA) N. Burns, M. Callahan, L. Flournoy, G

Slides:



Advertisements
Similar presentations
C E N T R A L P I E D M O N T C O M M U N I T Y C O L L E G E Pandemic and Influenza: A Guide to Understanding.
Advertisements

1 ‘School Closing’ as a Potential Means to Counter Pandemic Influenza Table Top Exercise (TTX)
BIRD FLU PANDEMIC PREPAREDNESS.
Respiratory Protection
Use and Limitation of N-95 Filtering Facepiece Environment, Health and Safety Occupational Health and Hygiene 2009.
Unit 7.2. Respirator fit testing TB Infection Control Training for Managers at National and Subnational Level.
International SOS Pandemic Planning PERSONAL PROTECTIVE EQUIPMENT (PPE) © 2009 International SOS Assistance, Inc.. All rights reserved. Unauthorized copy.
What To Do About The AVIAN FLU?. The Avian Flu? Is That Like a Cold? NO! The Avian Flu, according to the World Health Organization, is a large group of.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
W504 - Asbestos – personal protective equipment. Respiratory protection Exposure to asbestos should be prevented or reduced as far as reasonably practicable.
Developing a vaccine and how a pandemic could occur.
PANDEMIC RISK. 3 pre-requisites for a Pandemic 1. The emergence of a new virus strain with no circulating immunity within the human population 2. The.
1 ‘School Closing’ as a Potential Means to Counter Pandemic Influenza Table Top Exercise (TTX)
HOW DO VIRUSES CROSS THE SPECIES BARRIER? Rachel Rezabek.
Update: “New Flu” Activity and Community Mitigation Diane Woolard, PhD, MPH Director, Division of Surveillance and Investigation Virginia Department of.
Avian Influenza When avian influenza hits will science have an efficient vaccine?
HOW DO VIRUSES CROSS THE SPECIES BARRIER? Rachel Rezabek.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
University of Pittsburgh Senior Design - BioE Universal Facemask Adapter Nicole Burns Mike Callahan LaDahvia Flournoy Gabrielle Ramus Advisor:
Avian Flu Pandemic Preparedness David A. Denneno APRN,BC, MSN, MEd, CEN Emergency Preparedness Coordinator Sturdy Memorial Hospital Attleboro, MA.
Theories of Health Behaviors Gero 302. Health Belief Model Has intuitive Logic and clearly stated central tenents Behind the HBM values and expectancy.
Abstract Thoraco Lumbar Sacral Orthotic (TLSO) braces are used to immobilize the spine following injuries or surgical procedures. Current bi-valve brace.
The Vermont Department of Health Update on Pandemic Threat Cort Lohff, MD, MPH State Epidemiologist Guidance Support Prevention Protection.
TF_Arusha_Jun10/1 Framework for Evaluation of Male Circumcision Devices Tim Farley Department of Reproductive Health and Research World Health Organization.
Session 5: Selecting and Operationalizing Indicators.
Prevention and Control of Influenza A (H1N1) in the Workplace Engr. Nelia G. Granadillos Chief, Environment Control Division Occupational Safety and Health.
Down Syndrome Training The Center for Life Enrichment
Special Acknowledgments
OBJECTIVES Understanding what food chemicals are?
World Health Organization
Pandemic Influenza Planning
DATA COLLECTION METHODS IN NURSING RESEARCH
Avian Influenza A (H5N1) “Bird Flu”
Assessing Students' Understanding of the Scientific Process Amy Marion, Department of Biology, New Mexico State University Abstract The primary goal of.
Part VI—Influenza and EMTALA & Part VII– Planning Considerations
Table 1: NHBS HET3 Participant Characteristics
(Additional materials)
The Impact Of Pediatric Critical Illness, Injury, Complex Medical Conditions And Disabilities On Families Office of Rare Diseases and the National Institute.
Bruce Waslick, MD Medical Director UMass / Baystate MCPAP Team
Ensures compliance with OSHA 29 CFR
HIV in Ireland 2017 Provisional Data May 2018.
9.1 Assessing a change in scale
TYNDP: Ten-Year Network Development Plan 2016
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
LEC Incorporated 8 February 2005 Group Members: Jen Bacior Amine Hallab Hiroki Meguro Kevin Mihelc Advisors: Kelly Dympna, MD Jack Patzer, PhD Biopsy.
Testing Procedures.
Human- Environment Interaction
Fault Tree Analysis Universal Facemask Adapter
The Role of NICs in Influenza Surveillance
Defining Elimination of Genital Warts - A Delphi Study Dr Laila Khawar
Emergency Preparedness in the Florida State Courts
What do we mean by opioid sparing and what are its potential individual and societal benefits? Eric C. Strain, M.D. Johns Hopkins University School.
"Environmental Expenditure Statistics"
Chapter # 7 Software Quality Metrics
Volume 124, Issue 4, Pages (February 2006)
Designing and Manufacturing of a hand operated plastic injection moulding machine envisioned for the mesoscale range. Freddy Travieso
Influenza Pandemic: A Threats to Regional and National Health and Development CSRU, SEARD.
Prevention of Swine Flu
OSHA’s Respiratory Protection Standard 29 CFR
SUSTAINABLE MICRO-FINANCE for WOMEN’S EMPOWERMENT
Good Governance of Animal Health Systems
UAMS Department of Biochemistry and Molecular Biology
Analyzing social media data to monitor public health trends
Finnian Hanrahan Infectious diseases and public health
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
Testing Procedures Testing Procedures
Avian Influenza: Protecting Flocks, Protecting People
California State University Fresno
Presentation transcript:

Universal Facemask Adapter (UFA) N. Burns, M. Callahan, L. Flournoy, G Universal Facemask Adapter (UFA) N. Burns, M. Callahan, L. Flournoy, G. Ramus The Impetus Widespread flu pandemics crippled the country and the world in 1918, 1957, and 1968. There is generally acceptance that whether a similar pandemic will occur is not a question of, “if” but rather, “when”. The next strain of influenza that may make the jump to pandemic status is hypothesized to be H5N1, more commonly known as avian influenza or the bird flu. Based on consultation with clinical advisors, the original intention for this senior design effort was design and development of a improved disposable particulate respirator that would effectively prevent passage of H5N1 virus-containing particulates into a healthcare providers’ airway while not impairing their ability to function in their particular job. Because it is not known what form the virus may take if it becomes capable of human-to-human transmission, this non-pharmaceutical intervention would likely be a highly desirable source of protection. After several reviews of possible designs, the concept was re-geared toward the creation of a gasket-type adaptor that would sit in between the user’s face and a preexisting mask to better seal any gaps that naturally exist due to the populations differing facial structures. This approach would allow existing masks—as well as any masks that may yet be developed— to be immediately improved allowing more effective and adequate protection from both avian flu and a variety of other infectious diseases. Testing Methodology Qualitative Fit Testing The testing used to validate the success of the prototypes involved a three stage process: Bitrex™ detection with sensitization, testing without the adapter, and testing with an adapter. Initially ten subjects who failed a respirator fit test without the use of the UFA was desired for testing Success of the Phase I prototypes would be based on the aforementioned subjects passing the qualitative fit test only when using the UFA. Results Currently, eleven subjects have been tested using the Bitrex™ method, four of which have failed the qualitative fit test without the use of the UFA Three of the four subjects who failed the fit test without the use of the UFA subsequently passed the fit test with the use of our product One subject who passed the initial fit test without the adapter failed the second fit test with the UFA A table summarizing the results of the Bitrex testing can be found below. Design Methodology Design Development The initial design and shape were created in SolidWorks 2006 (SolidWorks Corp., Waltham, MA) A prototype was created and the SolidWorks model was refined several times until the final shape and design was determined Foam Adapter Using the Solidworks models as a guide a prototype was created by hand out of Airtex high density foam. The dimensions of the foam adapter are show in Figure 1 below. The foam adapter costs approximately $0.60 to produce by hand, but with further refinement mass production could greatly reduce this cost Polyacrylamide Gel Adapter The desired shape of the adapter was transferred onto thin vinyl (PVC) sheeting, and a second sheet was then glued and heat sealed on top of it Non-toxic polyacrylamide gel was then injected into the space between the two vinyl sheets The cost per adapter is approximately $1.80, but this would decrease dramatically with larger scale production Without Adapter With Adapter Pass 7 9 Fail 4 2 Figure 3. Participant of the fit testing procedure. Discussion Although further testing must be done, the preliminary fit testing that was performed with the use of the Universal Facemask Adapter indicates the potential for success of the product. However, the Bitrex™ testing—due to its qualitative nature—is relatively subjective, and relies heavily on the perception of the subject being tested. It is recommended that for further testing a more quantitative test—such as PortaCount testing—is used. This would remove any potential bias that a subject may have, and would give the exact number of particulates that pass beyond the respirator. Also, the use of an adhesive to secure the UFA to both the mask and the subjects face should be tested for potential use with a final prototype. Further, to truly call this product universal, different styles of particulate respirators that are on the market must be tested with the adapter. Although only in a preliminary stage of development, results suggests the product warrants further pursuit. The economic benefit that may potentially arise due to the eventual elimination of fit testing, as well as the health and safety benefit to the intended user that the adapter would bring demand that the development of the Universal Facemask Adapter be continued. Figure 2. Polyacrylamide gel filled adapter 1.0” 1.0” 0.75” 0.50” Figure 1. Final design of the UFA with associated dimensions Acknowledgments Special thanks to the generous gift of Drs. Hal Wrigley and Linda Baker, the BioEngineering Department, Andy Holmes, Virginia Dato, MD, MPH—PA Department of Public Heath, and Eric Toner, MD—UPMC Center for Biosecurity